Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppina Catanzaro

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
International Journal of Molecular Sciences|December 21, 2017
Loss of miR-107, miR-181c and miR-29a-3p Promote Activation of Notch2 Signaling in Pediatric High-Grade Gliomas (pHGGs)Giuseppina Catanzaro, Claudia Sabato, Michele Russo, et al.
Environmental Research|November 29, 2025
Bisphenol A triggers adipocyte dysfunction, thereby fostering triple-negative breast cancer aggressivenessAnna Citarella, Tanja Milena Autilio, Zein Mersini Besharat, et al.
Biomarker Research|September 19, 2023
Circulating cell-free DNA (cfDNA) in patients with medullary thyroid carcinoma is characterized by specific fragmentation and methylation changes with diagnostic valueAnna Citarella, Zein Mersini Besharat, Sofia Trocchianesi, et al.
Diagnostics (Basel, Switzerland)|August 19, 2020
Low-Grade Gliomas in Patients with Noonan Syndrome: Case-Based Review of the LiteratureMariachiara Lodi, Luigi Boccuto, Andrea Carai, et al.
Molecular Oncology|September 13, 2020
Downregulation of miR-326 and its host gene β-arrestin1 induces pro-survival activity of E2F1 and promotes medulloblastoma growthEvelina Miele, Agnese Po, Angela Mastronuzzi, et al.
Biomarker Research|June 17, 2022
MiR-1248: a new prognostic biomarker able to identify supratentorial hemispheric pediatric low-grade gliomas patients associated with progressionGiuseppina Catanzaro, Zein Mersini Besharat, Andrea Carai, et al.
Biomedicines|January 25, 2025
MicroRNAs Expression Profile in MN1-Altered AstroblastomaFrancesca Gianno, Evelina Miele, Claudia Sabato, et al.
International Journal of Cancer|December 15, 2020
Upfront treatment with mTOR inhibitor everolimus in pediatric low-grade gliomas: A single-center experienceAntonella Cacchione, Mariachiara Lodi, Andrea Carai, et al.
Communications Medicine|May 7, 2026
Circulating EV-microRNAs are dynamic biomarkers of resistance to therapeutic immunomodulation in metastatic melanomaElena Splendiani, Zein Mersini Besharat, Claudia Sabato, et al.
Molecular Therapy. Nucleic Acids|June 3, 2026
Exploration of miR-326 delivery via biocompatible polymeric nanoparticles in medulloblastoma: A preliminary studyElena Splendiani, Gabriele Maiorano, Zaira Spinello, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
International Journal of Molecular Sciences|December 21, 2017
Loss of miR-107, miR-181c and miR-29a-3p Promote Activation of Notch2 Signaling in Pediatric High-Grade Gliomas (pHGGs)Giuseppina Catanzaro, Claudia Sabato, Michele Russo, et al.
Environmental Research|November 29, 2025
Bisphenol A triggers adipocyte dysfunction, thereby fostering triple-negative breast cancer aggressivenessAnna Citarella, Tanja Milena Autilio, Zein Mersini Besharat, et al.
Biomarker Research|September 19, 2023
Circulating cell-free DNA (cfDNA) in patients with medullary thyroid carcinoma is characterized by specific fragmentation and methylation changes with diagnostic valueAnna Citarella, Zein Mersini Besharat, Sofia Trocchianesi, et al.
Diagnostics (Basel, Switzerland)|August 19, 2020
Low-Grade Gliomas in Patients with Noonan Syndrome: Case-Based Review of the LiteratureMariachiara Lodi, Luigi Boccuto, Andrea Carai, et al.
Molecular Oncology|September 13, 2020
Downregulation of miR-326 and its host gene β-arrestin1 induces pro-survival activity of E2F1 and promotes medulloblastoma growthEvelina Miele, Agnese Po, Angela Mastronuzzi, et al.
Biomarker Research|June 17, 2022
MiR-1248: a new prognostic biomarker able to identify supratentorial hemispheric pediatric low-grade gliomas patients associated with progressionGiuseppina Catanzaro, Zein Mersini Besharat, Andrea Carai, et al.
Biomedicines|January 25, 2025
MicroRNAs Expression Profile in MN1-Altered AstroblastomaFrancesca Gianno, Evelina Miele, Claudia Sabato, et al.
International Journal of Cancer|December 15, 2020
Upfront treatment with mTOR inhibitor everolimus in pediatric low-grade gliomas: A single-center experienceAntonella Cacchione, Mariachiara Lodi, Andrea Carai, et al.
Communications Medicine|May 7, 2026
Circulating EV-microRNAs are dynamic biomarkers of resistance to therapeutic immunomodulation in metastatic melanomaElena Splendiani, Zein Mersini Besharat, Claudia Sabato, et al.
Molecular Therapy. Nucleic Acids|June 3, 2026
Exploration of miR-326 delivery via biocompatible polymeric nanoparticles in medulloblastoma: A preliminary studyElena Splendiani, Gabriele Maiorano, Zaira Spinello, et al.
Pageof 7